$VICR

Schmidt James F sold $126K of VICR

Schmidt James F (CFO, Treasurer, Secretary) sold 400 shares of VICOR CORP (VICR) at $314.86 ($0.13M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Schmidt James F
Published Jun 2, 2026, 5:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 5:05 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The disclosure provides incremental sentiment information but does not introduce new company fundamentals (no guidance, deal, or litigation).

02

Market read

Traders may monitor for follow-on insider activity, but this specific filing is unlikely to drive a durable repricing without additional fundamental news.

03

What to watch

Check whether there are multiple recent insider transactions or changes in trading patterns; a single 10b5-1 sale is usually less informative than clustered activity.

Relevance 6/10Novelty 6/10Timing: Filed today; transaction dated 2026-06-01 (post-trade disclosure).

Background

SEC Form 4 reports insider transactions; Rule 10b5-1 plans are pre-scheduled trades intended to reduce timing/insider-information concerns.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

ViCOR Corp CFO/Treasurer/Secretary James F. Schmidt sold $125,942 of VICR shares via an open-market sale under a 10b5-1 plan.

Expected impact

Limited/short-lived impact; any reaction is likely sentiment-driven rather than a new fundamental catalyst.

Evidence & confidence

The filing is a routine insider transaction and explicitly states a pre-arranged 10b5-1 plan, reducing the probability of an information-driven sale.

Market effects

No direct sector read-through; this is company-specific insider activity.

None.

None.

Counterpoint

Because the sale is under a 10b5-1 plan, the market may overreact; price may mean-revert if no other catalysts exist.

Key entities

  • VICOR CORP

    Subject of the insider transaction disclosure (Form 4).

  • Schmidt James F

    CFO/Treasurer/Secretary who sold 400 shares under a 10b5-1 plan.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: